Status:

COMPLETED

Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India

Lead Sponsor:

Harvard School of Public Health (HSPH)

Collaborating Sponsors:

Foundation for Medical Research

Municipal Corporation of Greater Mumbai, India

Conditions:

Multi-drug Resistant Tuberculosis

Eligibility:

All Genders

18-60 years

Brief Summary

India has the highest incidence of and mortality from multi-drug resistant tuberculosis (MDR-TB) globally. Vitamin D status may be an important determinant of MDR-TB infection and treatment outcomes; ...

Detailed Description

To combat the substantial global burdens of TB and MDR-TB, novel treatment strategies and expanded prevention efforts are critical. Although vitamin D supplementation shows promise in both of these ar...

Eligibility Criteria

Inclusion

  • Inclusion criteria for cases:
  • Currently receiving outpatient treatment for MDR-TB according to standard of care (including new cases and those who have been on treatment for no more than one month)
  • Residence in Mumbai M/E, M/W or H/E ward for at least six months
  • 18-60 years old
  • Permanently living with at least two eligible controls
  • Confirmation that they have disclosed their TB status to household and will allow inclusion of their household members in the study
  • Inclusion criteria for household contact controls:
  • Was a permanent member of the index case's household for at least one year prior to the case's DR TB diagnosis
  • No symptoms of active TB disease
  • Residence in Mumbai M/E, M/W or H/E ward for at least six months
  • 18-60 years old
  • Inclusion criteria for non-household controls:
  • 18 - 60 years of age
  • Residence in Mumbai M/E, M/W or H/E ward for at least six months
  • No symptoms of active TB disease
  • No history of household contact with a TB patient in last 2 years
  • Exclusion criterion for both cases and controls:
  • • Pregnancy.

Exclusion

    Key Trial Info

    Start Date :

    January 27 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 17 2020

    Estimated Enrollment :

    352 Patients enrolled

    Trial Details

    Trial ID

    NCT04342598

    Start Date

    January 27 2020

    End Date

    December 17 2020

    Last Update

    February 25 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Foundations for Medical Research

    Mumbai, Maharashtra, India, 400 018